FEB 16, 2018 7:15 AM PST

Treating Untreatable Heart Failure with Cardiac Macrophages

WRITTEN BY: Kara Marker

Immune cells called macrophages contribute to an untreatable type of heart failure. At least, this type of heart failure is untreatable for the time being. From Massachusetts General Hospital (MGH), scientists identify key differences between how different types of heart failure develop. Bringing these differences to light could aid in the creation of new treatments for heart failure.

A macrophage of a mouse forming two processes to phagocytize two smaller particles, possibly pathogens. Credit: Wikimedia user magnaram

A specific type of heart failure characterized by “preserved ejection fraction” is also called diastolic heart failure. Ejection fraction is a measure of how much blood is getting pumped out the heart with each heartbeat. When ejection fraction is “preserved,” it means that the heart is contracting normally, but its ventricles do not relax normally.

Diastolic heart failure is directly compared to systolic heart failure, a result of “reduced” ejection fraction. This type of heart failure deals with the opposite problem: the heart muscle’s inability to contract normally.

Symptoms of both diastolic and systolic heart failure are similar, but it’s very likely that each condition requires a different treatment approach. In the present study, MGH scientists focus on diastolic heart failure, which makes up about 50 percent of all human heart failure cases.

"We show that macrophages - white blood cells primarily known for removing cellular debris, pathogens and other unwanted materials - are actively involved in the development of [preserved ejection fraction]," explained lead author Maarten Hulsmans, PhD, from MGH. "These findings put macrophages on the map when it comes to [diastolic heart failure] therapy and open up previously unexplored treatment options."

To identify a potential set of solutions for diastolic heart failure, scientists first needed to better understand how the disease develops: when cellular interactions in the heart, including macrophages, lead to disease instead of promoting normal heart activities.

In a healthy response, macrophages activate cells called fibroblasts to “reinforce” tissue damaged by a heart attack. But if macrophages activate too many fibroblasts, damaged tissues become stiff, which only makes cardiac function worse.

In their study, researchers used two mouse models of diastolic heart failure, assessing the cellular repercussions of preserved ejection fraction. Initially, they saw elevated levels of macrophages in the left ventricle as well as more evidence of interleukin (IL)-10, a chemical messenger of the immune system that promotes fibroblast activation.

In one of the models, research induced IL-10 deficiency in cardiac macrophages. This resulted in lower macrophage levels and, subsequently, lower cardiac fibroblast activity.

"Through their participation in the remodeling of heart tissue, these macrophages increase the production of extracellular matrix, which reduces diastolic relaxation,” Hulsmans explained. “Our findings regarding the cell-specific knockout of IL-10 are the first to support the contribution of macrophages to [diastolic heart failure]."

With the findings from Hulsmans’s new study come hopes for new drug development based on the new understanding of the relationship between heart muscle cells, macrophages, and fibroblasts.

The present study was published in the Journal of Experimental Medicine.

Sources: American Heart Association, Massachusetts General Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 05, 2020
Immunology
Intercepting Cancer Cells Before They Can Dodge the Immune System
AUG 05, 2020
Intercepting Cancer Cells Before They Can Dodge the Immune System
The battle that naturally occurs between the body’s immune system and cancerous cells is one that scientists have ...
AUG 18, 2020
Immunology
How Dolphins Could Help Us Live Longer
AUG 18, 2020
How Dolphins Could Help Us Live Longer
Dolphins are helping scientists answer the age-old question: can we stop the clock when it comes to aging? A recent stud ...
AUG 19, 2020
Immunology
Cancer Mutation Improves Chemo Drug Performance
AUG 19, 2020
Cancer Mutation Improves Chemo Drug Performance
When it comes to cancer biomarkers, it’s often the genetic signatures that are associated with poor patient outcom ...
AUG 27, 2020
Immunology
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
AUG 27, 2020
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
  Living medicines in the form of stem cell therapies have immense potential for their ability to regenerate and he ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
NOV 04, 2020
Coronavirus
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
NOV 04, 2020
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
COVID-19, the illness caused by the pandemic virus SARS-CoV-2, is known to cause blood clots all over the body in some p ...
Loading Comments...